nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C8—Sorafenib—thyroid cancer	0.0427	0.331	CbGbCtD
Zopiclone—CYP2C9—Sorafenib—thyroid cancer	0.0298	0.231	CbGbCtD
Zopiclone—CYP3A4—Vandetanib—thyroid cancer	0.0288	0.223	CbGbCtD
Zopiclone—CYP3A4—Sorafenib—thyroid cancer	0.0173	0.134	CbGbCtD
Zopiclone—CYP3A4—Doxorubicin—thyroid cancer	0.0105	0.0814	CbGbCtD
Zopiclone—GABRA3—neck—thyroid cancer	0.00485	0.117	CbGeAlD
Zopiclone—TSPO—neck—thyroid cancer	0.00335	0.0807	CbGeAlD
Zopiclone—GABRG3—head—thyroid cancer	0.00286	0.0691	CbGeAlD
Zopiclone—TSPO—saliva-secreting gland—thyroid cancer	0.00261	0.063	CbGeAlD
Zopiclone—GABRA3—thyroid gland—thyroid cancer	0.00231	0.0557	CbGeAlD
Zopiclone—GABRA5—head—thyroid cancer	0.0022	0.0531	CbGeAlD
Zopiclone—GABRA3—head—thyroid cancer	0.00205	0.0494	CbGeAlD
Zopiclone—TSPO—trachea—thyroid cancer	0.00201	0.0486	CbGeAlD
Zopiclone—Dizziness—Vandetanib—thyroid cancer	0.00176	0.00212	CcSEcCtD
Zopiclone—Vaginal infection—Epirubicin—thyroid cancer	0.00175	0.00211	CcSEcCtD
Zopiclone—Coordination abnormal—Doxorubicin—thyroid cancer	0.00175	0.00211	CcSEcCtD
Zopiclone—Neuropathy—Epirubicin—thyroid cancer	0.00174	0.0021	CcSEcCtD
Zopiclone—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00172	0.00207	CcSEcCtD
Zopiclone—Hiccups—Doxorubicin—thyroid cancer	0.00172	0.00207	CcSEcCtD
Zopiclone—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00172	0.00207	CcSEcCtD
Zopiclone—Dry eye—Epirubicin—thyroid cancer	0.00172	0.00207	CcSEcCtD
Zopiclone—Anorexia—Sorafenib—thyroid cancer	0.00171	0.00206	CcSEcCtD
Zopiclone—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00171	0.00206	CcSEcCtD
Zopiclone—Abnormal dreams—Doxorubicin—thyroid cancer	0.0017	0.00205	CcSEcCtD
Zopiclone—Dermatitis contact—Doxorubicin—thyroid cancer	0.0017	0.00205	CcSEcCtD
Zopiclone—Vomiting—Vandetanib—thyroid cancer	0.00169	0.00204	CcSEcCtD
Zopiclone—Rash maculo-papular—Epirubicin—thyroid cancer	0.00169	0.00203	CcSEcCtD
Zopiclone—Bladder pain—Epirubicin—thyroid cancer	0.00168	0.00202	CcSEcCtD
Zopiclone—Mouth ulceration—Epirubicin—thyroid cancer	0.00168	0.00202	CcSEcCtD
Zopiclone—Melaena—Doxorubicin—thyroid cancer	0.00168	0.00202	CcSEcCtD
Zopiclone—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00168	0.00202	CcSEcCtD
Zopiclone—Rash—Vandetanib—thyroid cancer	0.00168	0.00202	CcSEcCtD
Zopiclone—Dermatitis—Vandetanib—thyroid cancer	0.00167	0.00202	CcSEcCtD
Zopiclone—GABRG2—head—thyroid cancer	0.00167	0.0403	CbGeAlD
Zopiclone—GABRB2—head—thyroid cancer	0.00167	0.0403	CbGeAlD
Zopiclone—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00167	0.00201	CcSEcCtD
Zopiclone—Headache—Vandetanib—thyroid cancer	0.00166	0.00201	CcSEcCtD
Zopiclone—Cystitis—Doxorubicin—thyroid cancer	0.00166	0.002	CcSEcCtD
Zopiclone—Colitis—Doxorubicin—thyroid cancer	0.00165	0.00199	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00163	0.00197	CcSEcCtD
Zopiclone—Hypertonia—Epirubicin—thyroid cancer	0.00163	0.00196	CcSEcCtD
Zopiclone—Vaginal infection—Doxorubicin—thyroid cancer	0.00162	0.00196	CcSEcCtD
Zopiclone—Neuropathy—Doxorubicin—thyroid cancer	0.00161	0.00194	CcSEcCtD
Zopiclone—Mental disability—Epirubicin—thyroid cancer	0.00161	0.00194	CcSEcCtD
Zopiclone—Dyspnoea—Sorafenib—thyroid cancer	0.0016	0.00193	CcSEcCtD
Zopiclone—TSPO—thyroid gland—thyroid cancer	0.00159	0.0384	CbGeAlD
Zopiclone—Dry eye—Doxorubicin—thyroid cancer	0.00159	0.00191	CcSEcCtD
Zopiclone—Lymphadenopathy—Epirubicin—thyroid cancer	0.00158	0.0019	CcSEcCtD
Zopiclone—Nausea—Vandetanib—thyroid cancer	0.00158	0.0019	CcSEcCtD
Zopiclone—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00158	0.0019	CcSEcCtD
Zopiclone—Dyspepsia—Sorafenib—thyroid cancer	0.00158	0.0019	CcSEcCtD
Zopiclone—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00156	0.00188	CcSEcCtD
Zopiclone—Decreased appetite—Sorafenib—thyroid cancer	0.00156	0.00188	CcSEcCtD
Zopiclone—Thrombophlebitis—Epirubicin—thyroid cancer	0.00156	0.00188	CcSEcCtD
Zopiclone—Bladder pain—Doxorubicin—thyroid cancer	0.00155	0.00187	CcSEcCtD
Zopiclone—Mouth ulceration—Doxorubicin—thyroid cancer	0.00155	0.00187	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00155	0.00187	CcSEcCtD
Zopiclone—Fatigue—Sorafenib—thyroid cancer	0.00155	0.00186	CcSEcCtD
Zopiclone—Photosensitivity—Epirubicin—thyroid cancer	0.00154	0.00185	CcSEcCtD
Zopiclone—Constipation—Sorafenib—thyroid cancer	0.00153	0.00185	CcSEcCtD
Zopiclone—Pain—Sorafenib—thyroid cancer	0.00153	0.00185	CcSEcCtD
Zopiclone—GABRA2—head—thyroid cancer	0.00153	0.0368	CbGeAlD
Zopiclone—Hypertonia—Doxorubicin—thyroid cancer	0.00151	0.00182	CcSEcCtD
Zopiclone—Eczema—Epirubicin—thyroid cancer	0.0015	0.00181	CcSEcCtD
Zopiclone—Mental disability—Doxorubicin—thyroid cancer	0.00149	0.0018	CcSEcCtD
Zopiclone—GABRA1—head—thyroid cancer	0.00148	0.0356	CbGeAlD
Zopiclone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00147	0.00177	CcSEcCtD
Zopiclone—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00146	0.00176	CcSEcCtD
Zopiclone—GABRB3—thyroid gland—thyroid cancer	0.00145	0.0349	CbGeAlD
Zopiclone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00144	0.00174	CcSEcCtD
Zopiclone—Increased appetite—Epirubicin—thyroid cancer	0.00143	0.00173	CcSEcCtD
Zopiclone—Urticaria—Sorafenib—thyroid cancer	0.00142	0.00172	CcSEcCtD
Zopiclone—Photosensitivity—Doxorubicin—thyroid cancer	0.00142	0.00171	CcSEcCtD
Zopiclone—Abdominal pain—Sorafenib—thyroid cancer	0.00142	0.00171	CcSEcCtD
Zopiclone—Body temperature increased—Sorafenib—thyroid cancer	0.00142	0.00171	CcSEcCtD
Zopiclone—TSPO—head—thyroid cancer	0.00141	0.0341	CbGeAlD
Zopiclone—Dermatitis bullous—Epirubicin—thyroid cancer	0.00141	0.0017	CcSEcCtD
Zopiclone—Eczema—Doxorubicin—thyroid cancer	0.00139	0.00167	CcSEcCtD
Zopiclone—Diplopia—Epirubicin—thyroid cancer	0.00135	0.00163	CcSEcCtD
Zopiclone—Osteoarthritis—Epirubicin—thyroid cancer	0.00135	0.00163	CcSEcCtD
Zopiclone—Increased appetite—Doxorubicin—thyroid cancer	0.00133	0.0016	CcSEcCtD
Zopiclone—Migraine—Epirubicin—thyroid cancer	0.00133	0.0016	CcSEcCtD
Zopiclone—Affect lability—Epirubicin—thyroid cancer	0.00133	0.0016	CcSEcCtD
Zopiclone—Hypersensitivity—Sorafenib—thyroid cancer	0.00132	0.00159	CcSEcCtD
Zopiclone—Dermatitis bullous—Doxorubicin—thyroid cancer	0.0013	0.00157	CcSEcCtD
Zopiclone—Face oedema—Epirubicin—thyroid cancer	0.0013	0.00157	CcSEcCtD
Zopiclone—Asthenia—Sorafenib—thyroid cancer	0.00129	0.00155	CcSEcCtD
Zopiclone—GABRB3—head—thyroid cancer	0.00128	0.031	CbGeAlD
Zopiclone—Mood swings—Epirubicin—thyroid cancer	0.00128	0.00154	CcSEcCtD
Zopiclone—Pruritus—Sorafenib—thyroid cancer	0.00127	0.00153	CcSEcCtD
Zopiclone—Ataxia—Epirubicin—thyroid cancer	0.00127	0.00153	CcSEcCtD
Zopiclone—Dehydration—Epirubicin—thyroid cancer	0.00125	0.00151	CcSEcCtD
Zopiclone—Osteoarthritis—Doxorubicin—thyroid cancer	0.00125	0.0015	CcSEcCtD
Zopiclone—Diplopia—Doxorubicin—thyroid cancer	0.00125	0.0015	CcSEcCtD
Zopiclone—Dry skin—Epirubicin—thyroid cancer	0.00124	0.00149	CcSEcCtD
Zopiclone—Migraine—Doxorubicin—thyroid cancer	0.00123	0.00148	CcSEcCtD
Zopiclone—Affect lability—Doxorubicin—thyroid cancer	0.00123	0.00148	CcSEcCtD
Zopiclone—Hypokalaemia—Epirubicin—thyroid cancer	0.00123	0.00148	CcSEcCtD
Zopiclone—Diarrhoea—Sorafenib—thyroid cancer	0.00123	0.00148	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00121	0.00146	CcSEcCtD
Zopiclone—Face oedema—Doxorubicin—thyroid cancer	0.0012	0.00145	CcSEcCtD
Zopiclone—Gastritis—Epirubicin—thyroid cancer	0.00119	0.00144	CcSEcCtD
Zopiclone—Muscular weakness—Epirubicin—thyroid cancer	0.00119	0.00143	CcSEcCtD
Zopiclone—Dizziness—Sorafenib—thyroid cancer	0.00119	0.00143	CcSEcCtD
Zopiclone—Mood swings—Doxorubicin—thyroid cancer	0.00118	0.00142	CcSEcCtD
Zopiclone—Ataxia—Doxorubicin—thyroid cancer	0.00117	0.00141	CcSEcCtD
Zopiclone—Asthma—Epirubicin—thyroid cancer	0.00116	0.0014	CcSEcCtD
Zopiclone—Influenza—Epirubicin—thyroid cancer	0.00116	0.0014	CcSEcCtD
Zopiclone—Dysphagia—Epirubicin—thyroid cancer	0.00116	0.0014	CcSEcCtD
Zopiclone—Dehydration—Doxorubicin—thyroid cancer	0.00116	0.0014	CcSEcCtD
Zopiclone—Dry skin—Doxorubicin—thyroid cancer	0.00114	0.00138	CcSEcCtD
Zopiclone—Vomiting—Sorafenib—thyroid cancer	0.00114	0.00137	CcSEcCtD
Zopiclone—Hypokalaemia—Doxorubicin—thyroid cancer	0.00114	0.00137	CcSEcCtD
Zopiclone—Rash—Sorafenib—thyroid cancer	0.00113	0.00136	CcSEcCtD
Zopiclone—Dermatitis—Sorafenib—thyroid cancer	0.00113	0.00136	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00112	0.00135	CcSEcCtD
Zopiclone—Headache—Sorafenib—thyroid cancer	0.00112	0.00135	CcSEcCtD
Zopiclone—PTGS1—trachea—thyroid cancer	0.00112	0.027	CbGeAlD
Zopiclone—Bronchitis—Epirubicin—thyroid cancer	0.00112	0.00135	CcSEcCtD
Zopiclone—Gastritis—Doxorubicin—thyroid cancer	0.0011	0.00133	CcSEcCtD
Zopiclone—Muscular weakness—Doxorubicin—thyroid cancer	0.0011	0.00133	CcSEcCtD
Zopiclone—Dysuria—Epirubicin—thyroid cancer	0.00109	0.00131	CcSEcCtD
Zopiclone—Influenza—Doxorubicin—thyroid cancer	0.00108	0.0013	CcSEcCtD
Zopiclone—Dysphagia—Doxorubicin—thyroid cancer	0.00108	0.0013	CcSEcCtD
Zopiclone—Asthma—Doxorubicin—thyroid cancer	0.00108	0.0013	CcSEcCtD
Zopiclone—Pollakiuria—Epirubicin—thyroid cancer	0.00108	0.0013	CcSEcCtD
Zopiclone—GABRA2—lymph node—thyroid cancer	0.00107	0.0258	CbGeAlD
Zopiclone—Nausea—Sorafenib—thyroid cancer	0.00106	0.00128	CcSEcCtD
Zopiclone—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00106	0.00128	CcSEcCtD
Zopiclone—Weight increased—Epirubicin—thyroid cancer	0.00106	0.00128	CcSEcCtD
Zopiclone—Weight decreased—Epirubicin—thyroid cancer	0.00105	0.00127	CcSEcCtD
Zopiclone—Drowsiness—Epirubicin—thyroid cancer	0.00104	0.00125	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—thyroid cancer	0.00104	0.00125	CcSEcCtD
Zopiclone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00102	0.00123	CcSEcCtD
Zopiclone—Stomatitis—Epirubicin—thyroid cancer	0.00101	0.00122	CcSEcCtD
Zopiclone—Urinary tract infection—Epirubicin—thyroid cancer	0.00101	0.00122	CcSEcCtD
Zopiclone—Conjunctivitis—Epirubicin—thyroid cancer	0.00101	0.00122	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—thyroid cancer	0.00101	0.00122	CcSEcCtD
Zopiclone—Sweating—Epirubicin—thyroid cancer	0.000996	0.0012	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—thyroid cancer	0.000996	0.0012	CcSEcCtD
Zopiclone—Haematuria—Epirubicin—thyroid cancer	0.00099	0.00119	CcSEcCtD
Zopiclone—TSPO—lymph node—thyroid cancer	0.00099	0.0239	CbGeAlD
Zopiclone—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000984	0.00119	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—thyroid cancer	0.000981	0.00118	CcSEcCtD
Zopiclone—Epistaxis—Epirubicin—thyroid cancer	0.00098	0.00118	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—thyroid cancer	0.000975	0.00118	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—thyroid cancer	0.000961	0.00116	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000942	0.00114	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—thyroid cancer	0.000937	0.00113	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—thyroid cancer	0.000935	0.00113	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000934	0.00113	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000934	0.00113	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—thyroid cancer	0.000932	0.00112	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—thyroid cancer	0.000928	0.00112	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—thyroid cancer	0.000925	0.00112	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—thyroid cancer	0.000921	0.00111	CcSEcCtD
Zopiclone—CYP2E1—thyroid gland—thyroid cancer	0.00092	0.0222	CbGeAlD
Zopiclone—Oedema peripheral—Epirubicin—thyroid cancer	0.000919	0.00111	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—thyroid cancer	0.000916	0.0011	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—thyroid cancer	0.000907	0.00109	CcSEcCtD
Zopiclone—PTGS1—thyroid gland—thyroid cancer	0.000887	0.0214	CbGeAlD
Zopiclone—Erythema multiforme—Epirubicin—thyroid cancer	0.000882	0.00106	CcSEcCtD
Zopiclone—Tinnitus—Epirubicin—thyroid cancer	0.000869	0.00105	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—thyroid cancer	0.000865	0.00104	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—thyroid cancer	0.000863	0.00104	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000858	0.00104	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—thyroid cancer	0.000856	0.00103	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—thyroid cancer	0.00085	0.00102	CcSEcCtD
Zopiclone—Chills—Epirubicin—thyroid cancer	0.000837	0.00101	CcSEcCtD
Zopiclone—Alopecia—Epirubicin—thyroid cancer	0.000824	0.000994	CcSEcCtD
Zopiclone—CYP2E1—head—thyroid cancer	0.000816	0.0197	CbGeAlD
Zopiclone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000816	0.000984	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—thyroid cancer	0.000804	0.00097	CcSEcCtD
Zopiclone—Tension—Epirubicin—thyroid cancer	0.000797	0.00096	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—thyroid cancer	0.000795	0.000958	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—thyroid cancer	0.000788	0.000951	CcSEcCtD
Zopiclone—PTGS1—head—thyroid cancer	0.000787	0.019	CbGeAlD
Zopiclone—Back pain—Epirubicin—thyroid cancer	0.000785	0.000947	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—thyroid cancer	0.00078	0.000941	CcSEcCtD
Zopiclone—Chills—Doxorubicin—thyroid cancer	0.000774	0.000933	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—thyroid cancer	0.000765	0.000922	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—thyroid cancer	0.000762	0.000919	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000753	0.000908	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—thyroid cancer	0.00075	0.000905	CcSEcCtD
Zopiclone—Agitation—Epirubicin—thyroid cancer	0.000746	0.000899	CcSEcCtD
Zopiclone—Tension—Doxorubicin—thyroid cancer	0.000737	0.000889	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—thyroid cancer	0.000736	0.000887	CcSEcCtD
Zopiclone—Malaise—Epirubicin—thyroid cancer	0.000732	0.000883	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—thyroid cancer	0.000729	0.00088	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—thyroid cancer	0.000729	0.000879	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—thyroid cancer	0.000727	0.000876	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—thyroid cancer	0.000722	0.000871	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—thyroid cancer	0.000717	0.000865	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—thyroid cancer	0.000708	0.000853	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—thyroid cancer	0.000703	0.000848	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—thyroid cancer	0.000701	0.000845	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000697	0.00084	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—thyroid cancer	0.000694	0.000837	CcSEcCtD
Zopiclone—Chest pain—Epirubicin—thyroid cancer	0.000691	0.000833	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—thyroid cancer	0.000691	0.000833	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—thyroid cancer	0.00069	0.000832	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—thyroid cancer	0.000689	0.00083	CcSEcCtD
Zopiclone—Discomfort—Epirubicin—thyroid cancer	0.000683	0.000823	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—thyroid cancer	0.000677	0.000817	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—thyroid cancer	0.000676	0.000815	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—thyroid cancer	0.000675	0.000814	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—thyroid cancer	0.000668	0.000805	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—thyroid cancer	0.000664	0.0008	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000662	0.000799	CcSEcCtD
Zopiclone—Infection—Epirubicin—thyroid cancer	0.000658	0.000794	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—thyroid cancer	0.000651	0.000785	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—thyroid cancer	0.000648	0.000782	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—thyroid cancer	0.000647	0.00078	CcSEcCtD
Zopiclone—Hyperhidrosis—Epirubicin—thyroid cancer	0.00064	0.000772	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—thyroid cancer	0.000639	0.000771	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—thyroid cancer	0.000639	0.000771	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—thyroid cancer	0.000637	0.000768	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—thyroid cancer	0.000632	0.000762	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—thyroid cancer	0.000631	0.000761	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—thyroid cancer	0.000625	0.000754	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—thyroid cancer	0.000618	0.000745	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000613	0.000739	CcSEcCtD
Zopiclone—Infection—Doxorubicin—thyroid cancer	0.000609	0.000734	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000604	0.000728	CcSEcCtD
Zopiclone—Insomnia—Epirubicin—thyroid cancer	0.000599	0.000722	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—thyroid cancer	0.000598	0.000721	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—thyroid cancer	0.000595	0.000717	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000593	0.000714	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—thyroid cancer	0.000591	0.000712	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—thyroid cancer	0.000589	0.00071	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—thyroid cancer	0.000584	0.000705	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—thyroid cancer	0.000583	0.000703	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—thyroid cancer	0.000576	0.000694	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000572	0.00069	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—thyroid cancer	0.000571	0.000689	CcSEcCtD
Zopiclone—Pain—Epirubicin—thyroid cancer	0.000567	0.000683	CcSEcCtD
Zopiclone—Constipation—Epirubicin—thyroid cancer	0.000567	0.000683	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000558	0.000673	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—thyroid cancer	0.000554	0.000668	CcSEcCtD
Zopiclone—PTGS1—lymph node—thyroid cancer	0.000551	0.0133	CbGeAlD
Zopiclone—Paraesthesia—Doxorubicin—thyroid cancer	0.00055	0.000664	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—thyroid cancer	0.000547	0.000659	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—thyroid cancer	0.000546	0.000658	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—thyroid cancer	0.000545	0.000657	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000542	0.000653	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—thyroid cancer	0.00054	0.000651	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—thyroid cancer	0.000533	0.000642	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000529	0.000638	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—thyroid cancer	0.000528	0.000637	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—thyroid cancer	0.000526	0.000635	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—thyroid cancer	0.000524	0.000632	CcSEcCtD
Zopiclone—Pain—Doxorubicin—thyroid cancer	0.000524	0.000632	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—thyroid cancer	0.000524	0.000631	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—thyroid cancer	0.000524	0.000631	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000505	0.000609	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000501	0.000604	CcSEcCtD
Zopiclone—Hypersensitivity—Epirubicin—thyroid cancer	0.000488	0.000589	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—thyroid cancer	0.000487	0.000587	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—thyroid cancer	0.000485	0.000584	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—thyroid cancer	0.000485	0.000584	CcSEcCtD
Zopiclone—Asthenia—Epirubicin—thyroid cancer	0.000475	0.000573	CcSEcCtD
Zopiclone—Pruritus—Epirubicin—thyroid cancer	0.000469	0.000565	CcSEcCtD
Zopiclone—Diarrhoea—Epirubicin—thyroid cancer	0.000453	0.000547	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000452	0.000545	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—thyroid cancer	0.00044	0.00053	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—thyroid cancer	0.000438	0.000528	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—thyroid cancer	0.000434	0.000523	CcSEcCtD
Zopiclone—Vomiting—Epirubicin—thyroid cancer	0.000421	0.000508	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—thyroid cancer	0.000419	0.000506	CcSEcCtD
Zopiclone—Rash—Epirubicin—thyroid cancer	0.000418	0.000504	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—thyroid cancer	0.000417	0.000503	CcSEcCtD
Zopiclone—Headache—Epirubicin—thyroid cancer	0.000415	0.0005	CcSEcCtD
Zopiclone—Dizziness—Doxorubicin—thyroid cancer	0.000405	0.000489	CcSEcCtD
Zopiclone—Nausea—Epirubicin—thyroid cancer	0.000394	0.000474	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—thyroid cancer	0.00039	0.00047	CcSEcCtD
Zopiclone—Rash—Doxorubicin—thyroid cancer	0.000386	0.000466	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—thyroid cancer	0.000386	0.000466	CcSEcCtD
Zopiclone—Headache—Doxorubicin—thyroid cancer	0.000384	0.000463	CcSEcCtD
Zopiclone—Nausea—Doxorubicin—thyroid cancer	0.000364	0.000439	CcSEcCtD
